Suppr超能文献

miR-21-5p在肝细胞癌中的临床意义及分子机制研究:基于24项研究的系统评价和生物信息学研究

Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.

作者信息

Zhong Xiao-Zhu, Deng Yun, Chen Gang, Yang Hong

机构信息

Department of Medical Ultrasonics, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

出版信息

Oncol Lett. 2019 Jan;17(1):230-246. doi: 10.3892/ol.2018.9627. Epub 2018 Oct 26.

Abstract

To investigate the prospective roles and the clinicopathological application of microRNA-21-5p (miR-21-5p) in hepatocellular carcinoma (HCC), the present review is based on 24 studies and bioinformatics investigation. Firstly, HCC-associated miR-21-5p data were aggregated from literature databases and two public genomic data repositories, including the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA). Potential target genes of miR-21-5p in HCC were identified using TCGA and GEO, Natural Language Processing and 14 online software packages. The oncogenic roles of these target genes was probed for understanding using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analysis. Hub genes were further investigated by protein-protein interaction network (PPI) analysis. Comprehensive meta-analysis, including 10 microarrays from GEO datasets, 13 literature studies and TCGA-based RNA sequencing data, indicated a reliable diagnostic capacity of miR-21-5p [area under the curve (AUC), 0.887; sensitivity, 0.78% and specificity, 0.79%]. The healthy control group (AUC, 0.926; sensitivity, 0.87% and specificity, 0.82%) demonstrated high diagnostic capacity of miR-21-5p compared with the chronic hepatitis B infection group (AUC, 0.904; sensitivity, 0.75% and specificity, 0.84%). A total of 10 significant enrichment pathways were indicated by KEGG analysis, with cytokine-cytokine receptor interaction exhibiting the highest score. A total of 5 genes, hepatocyte growth factor, forkhead box O1 (FOXO1), thrombospondin 1, estrogen receptor 1 (ESR1) and C-X-C motif chemokine ligand 12 were selected from 39 overlapping genes, according to the PPI network. Target genes were assembled in GO terms associated with 'response to chemical stimulus', 'cell surface' and 'growth factor binding'. In particular, low expression of FOXO1 and ESR1 was associated with miR-21-5p expression. In conclusion, upregulated expression of miR-21-5p may be a functional regulator of the metabolism or apoptosis in HCC and a novel tumor marker for the early diagnosis of HCC.

摘要

为了研究微小RNA-21-5p(miR-21-5p)在肝细胞癌(HCC)中的潜在作用及临床病理应用,本综述基于24项研究和生物信息学调查。首先,从文献数据库以及两个公共基因组数据存储库(包括基因表达综合数据库(GEO)和癌症基因组图谱(TCGA))中汇总HCC相关的miR-21-5p数据。利用TCGA和GEO、自然语言处理以及14个在线软件包鉴定HCC中miR-21-5p的潜在靶基因。使用京都基因与基因组百科全书(KEGG)和基因本体论(GO)分析探究这些靶基因的致癌作用,以加深理解。通过蛋白质-蛋白质相互作用网络(PPI)分析进一步研究枢纽基因。综合荟萃分析纳入了来自GEO数据集的10个微阵列、13项文献研究以及基于TCGA的RNA测序数据,结果表明miR-21-5p具有可靠的诊断能力[曲线下面积(AUC)为0.887;灵敏度为0.78%,特异性为0.79%]。与慢性乙型肝炎感染组(AUC为0.904;灵敏度为0.75%,特异性为0.84%)相比,健康对照组(AUC为0.926;灵敏度为0.87%,特异性为0.82%)显示出miR-21-5p具有较高的诊断能力。KEGG分析共表明10条显著富集的通路,其中细胞因子-细胞因子受体相互作用得分最高。根据PPI网络,从39个重叠基因中选出了5个基因,即肝细胞生长因子、叉头框O1(FOXO1)、血小板反应蛋白1、雌激素受体1(ESR1)和C-X-C基序趋化因子配体12。靶基因按照与“对化学刺激的反应”“细胞表面”和“生长因子结合”相关的GO术语进行分类。特别是,FOXO1和ESR1的低表达与miR-21-5p表达相关。总之,miR-21-5p表达上调可能是HCC中代谢或凋亡的功能调节因子,也是HCC早期诊断的新型肿瘤标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/6313181/bb3e004083db/ol-17-01-0230-g00.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验